Cap Wealth Advisors, LLC Amgen Inc Transaction History

Cap Wealth Advisors, LLC

$903 Million
Q3 2024

A detailed history of Cap Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cap Wealth Advisors, LLC holds 29,428 shares of AMGN stock, worth $7.75 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

29,428

Previous 28,199 4.36%

Holding current value

$7.75 Million

Previous $8.81 Million 7.62%

% of portfolio

1.05%

Previous 1.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $380,228 - $414,640	1,229 Added 4.36%	29,428 $9.48 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $528,915 - $642,771	-2,013 Reduced 6.66%	28,199 $8.81 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $60,226 - $72,701	224 Added 0.75%	30,212 $8.59 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $89,495 - $100,961	350 Added 1.18%	29,988 $8.64 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $83,524 - $103,697	382 Added 1.31%	29,638 $7.97 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $19,070 - $22,549	-89 Reduced 0.3%	29,256 $6.5 Million
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $104,089 - $126,867	-461 Reduced 1.55%	29,345 $7.09 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $67,105 - $85,265	293 Added 0.99%	29,806 $7.83 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $38,158 - $43,035	170 Added 0.58%	29,513 $6.65 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $358,292 - $398,717	1,553 Added 5.59%	29,343 $7.14 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $50,212 - $55,548	229 Added 0.83%	27,790 $6.72 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $112,367 - $128,594	565 Added 2.09%	27,561 $6.2 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $4.87 Million - $5.71 Million	-22,946 Reduced 45.95%	26,996 $5.74 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $343,596 - $381,194	1,471 Added 3.03%	49,942 $12.2 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $227,457 - $265,065	1,025 Added 2.16%	48,471 $12.1 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $152,331 - $181,399	704 Added 1.51%	47,446 $10.9 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $140,086 - $155,787	597 Added 1.29%	46,742 $11.9 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $491,162 - $602,723	2,483 Added 5.69%	46,145 $10.9 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $1.21 Million - $1.61 Million	6,652 Added 17.97%	43,662 $8.85 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $957,306 - $1.27 Million	-5,253 Reduced 12.43%	37,010 $7.5 Million
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $83,820 - $107,737	443 Added 1.06%	42,263 $10.2 Million
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $837,469 - $1 Million	4,810 Added 13.0%	41,820 $8.09 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $612,455 - $717,936	3,674 Added 11.02%	37,010 $6.82 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $803,424 - $905,634	4,442 Added 15.37%	33,336 $6.33 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $2.84 Million - $3.32 Million	15,944 Added 123.12%	28,894 $5.63 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $417,273 - $470,420	2,252 Added 21.05%	12,950 $2.68 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $67,914 - $76,282	409 Added 3.98%	10,698 $1.98 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $62,180 - $72,666	367 Added 3.7%	10,289 $1.75 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $18,904 - $21,122	112 Added 1.14%	9,922 $1.73 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $74,778 - $85,377	-447 Reduced 4.36%	9,810 $1.83 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,257	10,257 $1.77 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cap Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cap Wealth Advisors, LLC with notifications on news.

Account

Cap Wealth Advisors, LLC Amgen Inc Transaction History